Cargando…

Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test

INTRODUCTION: Vestibular deficits are considered rare in children, but the lack of systematic screening leads to underdiagnosis. It has been demonstrated that chronic vestibular dysfunction impacts the normal psychomotor development of children. Early identification is needed to allow for clinical m...

Descripción completa

Detalles Bibliográficos
Autores principales: Monin, Emile, Bahim, Céline, Baussand, Lou, Cugnot, Jean-François, Ranieri, Maurizio, Guinand, Nils, Pérez Fornos, Angélica, Cao Van, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027694/
https://www.ncbi.nlm.nih.gov/pubmed/36959819
http://dx.doi.org/10.3389/fneur.2023.1085926
_version_ 1784909761598193664
author Monin, Emile
Bahim, Céline
Baussand, Lou
Cugnot, Jean-François
Ranieri, Maurizio
Guinand, Nils
Pérez Fornos, Angélica
Cao Van, Hélène
author_facet Monin, Emile
Bahim, Céline
Baussand, Lou
Cugnot, Jean-François
Ranieri, Maurizio
Guinand, Nils
Pérez Fornos, Angélica
Cao Van, Hélène
author_sort Monin, Emile
collection PubMed
description INTRODUCTION: Vestibular deficits are considered rare in children, but the lack of systematic screening leads to underdiagnosis. It has been demonstrated that chronic vestibular dysfunction impacts the normal psychomotor development of children. Early identification is needed to allow for clinical management, ensuring better global development. For this purpose, our research group has developed the Geneva Balance Test (GBT), aiming to objectively quantify the balance capacity of children over a broad age range, to screen for bilateral vestibulopathy (BV), and to quantify the improvement of balance abilities in children. METHODS: To determine the capacity of the GBT to quantify the balance capacity of children with BV, we conducted an observational prospective study with three populations: 11 children with BV, and two age-matched control groups composed of (1) 15 healthy subjects without the vestibular or auditory disorder (HS) and (2) 11 pediatric cochlear implant recipients (CIs) without vestibular disorders. Results of the three populations have been compared in three different age sub- groups (3–5, 6–9, and ≥10 years), and with results of a short, modified version of the Bruininks-Oseretsky test of Motor proficiency Ed. 2 (mBOT-2). RESULTS: Statistical analyses demonstrated significant differences in the scores of the GBT between children aged 3–5, 6–9, and ≥10 years with BV and in both control populations (HS and CI). BV scores reflected poorer balance capacities at all ages. Children in the youngest CI sub-group (3–5 years) showed intermediate GBT scores but reached HS scores at 6–9 years, reflecting an improvement in their balance capacities. All the results of the GBT were significantly correlated with mBOT-2 results, although only a few BV completed the entire mBOT-2. DISCUSSION: In this study, the GBT allowed quantifying balance deficits in children with BV. The BOT-2 test is not validated for children <4.5 years of age, and the GBT seems to be better tolerated in all populations than the mBOT-2. Furthermore, mBOT-2 results saturated, reaching maximum values by 6–9 years whereas the GBT did not, suggesting that the GBT could be a useful tool for monitoring the development of balance capacities with age and could be used in the follow-up of children with severe vestibular disorders.
format Online
Article
Text
id pubmed-10027694
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100276942023-03-22 Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test Monin, Emile Bahim, Céline Baussand, Lou Cugnot, Jean-François Ranieri, Maurizio Guinand, Nils Pérez Fornos, Angélica Cao Van, Hélène Front Neurol Neurology INTRODUCTION: Vestibular deficits are considered rare in children, but the lack of systematic screening leads to underdiagnosis. It has been demonstrated that chronic vestibular dysfunction impacts the normal psychomotor development of children. Early identification is needed to allow for clinical management, ensuring better global development. For this purpose, our research group has developed the Geneva Balance Test (GBT), aiming to objectively quantify the balance capacity of children over a broad age range, to screen for bilateral vestibulopathy (BV), and to quantify the improvement of balance abilities in children. METHODS: To determine the capacity of the GBT to quantify the balance capacity of children with BV, we conducted an observational prospective study with three populations: 11 children with BV, and two age-matched control groups composed of (1) 15 healthy subjects without the vestibular or auditory disorder (HS) and (2) 11 pediatric cochlear implant recipients (CIs) without vestibular disorders. Results of the three populations have been compared in three different age sub- groups (3–5, 6–9, and ≥10 years), and with results of a short, modified version of the Bruininks-Oseretsky test of Motor proficiency Ed. 2 (mBOT-2). RESULTS: Statistical analyses demonstrated significant differences in the scores of the GBT between children aged 3–5, 6–9, and ≥10 years with BV and in both control populations (HS and CI). BV scores reflected poorer balance capacities at all ages. Children in the youngest CI sub-group (3–5 years) showed intermediate GBT scores but reached HS scores at 6–9 years, reflecting an improvement in their balance capacities. All the results of the GBT were significantly correlated with mBOT-2 results, although only a few BV completed the entire mBOT-2. DISCUSSION: In this study, the GBT allowed quantifying balance deficits in children with BV. The BOT-2 test is not validated for children <4.5 years of age, and the GBT seems to be better tolerated in all populations than the mBOT-2. Furthermore, mBOT-2 results saturated, reaching maximum values by 6–9 years whereas the GBT did not, suggesting that the GBT could be a useful tool for monitoring the development of balance capacities with age and could be used in the follow-up of children with severe vestibular disorders. Frontiers Media S.A. 2023-03-07 /pmc/articles/PMC10027694/ /pubmed/36959819 http://dx.doi.org/10.3389/fneur.2023.1085926 Text en Copyright © 2023 Monin, Bahim, Baussand, Cugnot, Ranieri, Guinand, Pérez Fornos and Cao Van. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Monin, Emile
Bahim, Céline
Baussand, Lou
Cugnot, Jean-François
Ranieri, Maurizio
Guinand, Nils
Pérez Fornos, Angélica
Cao Van, Hélène
Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title_full Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title_fullStr Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title_full_unstemmed Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title_short Development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: The Geneva Balance Test
title_sort development of a new clinical tool to evaluate the balance abilities of children with bilateral vestibular loss: the geneva balance test
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027694/
https://www.ncbi.nlm.nih.gov/pubmed/36959819
http://dx.doi.org/10.3389/fneur.2023.1085926
work_keys_str_mv AT moninemile developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT bahimceline developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT baussandlou developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT cugnotjeanfrancois developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT ranierimaurizio developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT guinandnils developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT perezfornosangelica developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest
AT caovanhelene developmentofanewclinicaltooltoevaluatethebalanceabilitiesofchildrenwithbilateralvestibularlossthegenevabalancetest